IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus.

IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus.

<h4>Background</h4>The clinical utility of testing for antiphospholipid antibodies (aPL) of IgA isotype remains controversial.<h4>Methodology/principal findings</h4>To address this issue, we reasoned that if IgA aPL contribute to the clinical manifestations of the antiphospho...

Full description

Bibliographic Details
Main Authors: Nadera J Sweiss, Ronghai Bo, Reena Kapadia, Deborah Manst, Farzan Mahmood, Tara Adhikari, Suncica Volkov, Maria Badaracco, Mary Smaron, Anthony Chang, Joseph Baron, Jerrold S Levine
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-08-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20808864/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20808864/?tool=EBI

Similar Items